The Philadelphia Eagles there are no plans to bench quarterback Jalen Hurts on injured reserve as he deals with a superficial blood clot that will keep him on the sidelines indefinitely, ESPN’s Adam Schefter and Ian Rapoport report.
The team reportedly did not discuss the IR option, which would require at least four weeks of absence, though Hurts remains out while he and the organization gather more information and seek additional medical opinions.
Hurts’ health remains the main focus. The Eagles believe the clot is treatable, and the quarterback is working with the medical staff to determine the best course of action. Any decision on when he will return will come from his medical team, and the Eagles intend to follow that guidance.
However, Schefter and Rapoport indicate there is still a possibility he could end up on IR if further testing points in that direction.
The situation developed after a follow-up ultrasound revealed movement in the small blood clot, leading the team to rule Hurts out for Sunday’s game against the Carolina Panthers.. Treatment for such clots often involves blood thinners when movement occurs, which often prevents athletes from competing. A moderate dose may require at least six weeks, while a worsening clot may extend that to about three months.
Some within the organization view Hurts as week-to-week, though league doctors who have not examined him have estimated the potential absence at several weeks, with one saying it could be as long as six depending on size, location and further testing.
In Hurts’ absence, Tanner McKee is scheduled to start against Carolina. The Eagles also overhauled their quarterback depth, promoting rookie Cole Payton and signing Joe Milton from the Dallas Cowboys‘practice squad.
The development adds to a challenging stretch for Philadelphia, which has already navigated other significant injuries and roster changes this season. The team continues to prioritize a measured approach centered on Hurts’ long-term well-being as more medical details emerge.